Results 131 to 140 of about 115,969,812 (153)
Some of the next articles are maybe not open access.

An AAV variant selected through NHP screens robustly transduces the brain and drives secreted protein expression in NHPs and mice.

Science Translational Medicine
Recent work has shown that prolonged expression of recombinant proteins after adeno-associated virus (AAV)-mediated delivery of gene therapy to long-lived, ventricle-lining ependymal cells can profoundly affect disease phenotypes in animal models of ...
L. Tecedor   +12 more
semanticscholar   +1 more source

The gene encoding tripeptidyl peptidase II maps to Chromosome 1 in the mouse

Mammalian Genome, 1996
N A, Bermingham   +5 more
openaire   +2 more sources

Safety and efficacy of cerliponase alfa in children with neuronal ceroid lipofuscinosis type 2 (CLN2 disease): an open-label extension study.

Lancet Neurology
BACKGROUND Cerliponase alfa is a recombinant human tripeptidyl peptidase 1 (TPP1) enzyme replacement therapy for the treatment of neuronal ceroid lipofuscinosis type 2 (CLN2 disease), which is caused by mutations in the TPP1 gene.
A. Schulz   +16 more
semanticscholar   +1 more source

Tripeptidyl Peptidases: Enzymes That Count

Trends in Biochemical Sciences, 1999
Birgitta Tomkinson, B Tomkinson
exaly  

Axonal Transports of Tripeptidyl Peptidase II in Rat Sciatic Nerves

Neurochemistry International, 2007
Hiroshi Hojo
exaly  

Detection of Tripeptidyl Peptidase I Activity in Living Cells by Fluorogenic Substrates

Journal of Histochemistry and Cytochemistry, 2006
Robert Steinfeld, Jutta Gärtner
exaly  

Structure and Function of Tripeptidyl Peptidase II, a Giant Cytosolic Protease

Biochimica Et Biophysica Acta - Proteins and Proteomics, 2012
Wolfgang Baumeister   +2 more
exaly  

Home - About - Disclaimer - Privacy